The latest update is out from Tredegar Corp. (TG).
Tredegar Corporation announced an update on the Brazilian merger review process concerning the sale of its Terphane business to Oben Group, indicating a potential roadblock as the SG-CADE recommended against the transaction. However, this opinion is not final, and the case will progress to the CADE Tribunal for an independent analysis, with a final decision expected by November 18, 2024. The company remains cautiously optimistic, emphasizing that forward-looking statements involve risks and uncertainties that could affect the completion and timing of the sale.
Find detailed analytics on TG stock on TipRanks’ Stock Analysis page.
